Ionis to present at upcoming investor conferences

Rhea-AI Summary

Ionis Pharmaceuticals (Nasdaq: IONS), a leader in RNA-targeted therapeutics, will participate in upcoming virtual investor conferences, including the SVB Leerink 10th Annual Global Healthcare Conference on February 26, the Oppenheimer 31st Annual Healthcare Conference on March 17, and the J.P. Morgan 10th Annual Napa Valley Forum on March 29, 2021. Presentation details will be available on the Ionis website. The company is known for its pioneering work in RNA-targeted therapies and has a strong pipeline in neurological and cardiometabolic treatments.

CARLSBAD, Calif., Feb. 19, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, today announced that management will participate in a virtual fireside chat at the following investor conferences:

• SVB Leerink 10^th Annual Global Healthcare Conference on Friday, February 26, 2021;
• Oppenheimer 31^st Annual Healthcare Conference on Wednesday, March 17, 2021; and
• J.P. Morgan 10^th Annual Napa Valley Forum on Monday, March 29, 2021.

The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company's website. Please check www.ionispharma.com for the latest information.

A live webcast of the presentations will be available on the Investors & Media section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies.

To learn more about Ionis visit www.ionispharma.com and follow us on twitter @ionispharma.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301231383.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

What investor conferences will Ionis Pharmaceuticals attend in February and March 2021?

Ionis Pharmaceuticals will attend the SVB Leerink 10th Annual Global Healthcare Conference on February 26, Oppenheimer 31st Annual Healthcare Conference on March 17, and the J.P. Morgan 10th Annual Napa Valley Forum on March 29, 2021.

Where can I find the latest information on Ionis Pharmaceuticals' presentations?

The latest presentation information can be found on the Ionis Pharmaceuticals website at www.ionispharma.com.

Will Ionis Pharmaceuticals provide a live webcast of their conference presentations?

Yes, Ionis Pharmaceuticals will provide a live webcast of their presentations, available on the Investors & Media section of their website.

How long will the webcasts of Ionis Pharmaceuticals' presentations be available?

The replays of Ionis Pharmaceuticals' presentations will be available within 48 hours and will be archived for a limited time.

What is Ionis Pharmaceuticals known for?

Ionis Pharmaceuticals is known for being a leader in RNA-targeted therapies and for its innovative antisense technology, with a strong focus on neurological and cardiometabolic franchises.